Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder
Public ClinicalTrials.gov record NCT01211405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Triple-Blind, Phase 2 Pilot Study Comparing 3 Different Doses of MDMA in Conjunction With Manualized Therapy in 24 Veterans, Firefighters and Police Officers With Chronic Posttraumatic Stress Disorder (PTSD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to learn if MDMA-assisted therapy is safe and effective and reducing PTSD symptoms in veterans with chronic PTSD. The main question it aims to answer is: Do three doses of MDMA reduce PTSD symptoms? Researchers will compare 30, 75, and 125 mg of MDMA HCl with therapy to see which dose best reduces PTSD symptoms. Participants will undergo three preparatory non-drug therapy sessions with a male and female co-therapist team, then undergo three day-long MDMA-assisted therapy sessions after receiving an initial dose of 30, 75, or 125 mg MDMA HCl. After each MDMA-assisted therapy session, participants will undergo three integrative therapy sessions.
Study identification
- NCT ID
- NCT01211405
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Interventions
- Low dose MDMA-assisted therapy Drug
- Medium dose MDMA-assisted therapy Drug
- Full dose MDMA-assisted therapy Drug
- Therapy Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2010
- Primary completion
- Jun 3, 2015
- Completion
- Aug 1, 2016
- Last update posted
- Jun 4, 2025
2010 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Offices of Michael Mithoefer | Mt. Pleasant | South Carolina | 29464-4345 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Posttraumatic Stress Disorder trials
Other public records listing Posttraumatic Stress Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT05700201: Investigating Cardiac Health of Adults With Trauma Recruiting
- NCT07693686: Cognitive Training for Functioning in PTSD Not yet recruiting
- NCT06449326: Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms Recruiting
- NCT07656545: Early Intervention to Prevent Development of PTSD in Burn Survivors and Their Caregivers Not yet recruiting
- NCT04871100: Integrated CBT to Improve Functioning in Veterans With Anxiety and Substance Use Active, not recruiting
- NCT07250061: Self-Help Cognitive Processing Therapy (CPT)/Women Veterans Network (WoVeN) Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01211405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2025 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01211405 live on ClinicalTrials.gov.